Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study.
Inés Jiménez-LozanoJosé Manuel Caro-TellerNuria Fernández-HidalgoMarta MiaronsMarie Antoinette FrickEmma Batllori BadiaBerta SerranoCarlos Javier Parramón-TeixidóFátima Camba-LongueiraMaria Teresa Moral-PumaregaRafael San Juan-GarridoMaria Josep Cabañas PoyAnna SuyMaria Queralt Gorgas TornerPublished in: Journal of clinical pharmacy and therapeutics (2021)
It does not appear that tocilizumab has detrimental effects for the mother and newborn. Close monitoring of infections should be considered, especially if other immunosuppressive agents are used.